Compounds > phosphoribosyl-n-formylglycineamide
Page last updated: 2024-10-16

phosphoribosyl-n-formylglycineamide and Laryngeal Neoplasms

phosphoribosyl-n-formylglycineamide has been researched along with Laryngeal Neoplasms in 1 studies

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, LL1
Smithers, D1
Rose, LM1
Adamson, DJ1
Brockman, RW1

Other Studies

1 other study available for phosphoribosyl-n-formylglycineamide and Laryngeal Neoplasms

ArticleYear
Mode of action of 2-amino-6-chloro-1-deazapurine.
    Biochemical pharmacology, 1984, Jan-15, Volume: 33, Issue:2

    Topics: 2-Aminopurine; Adenine; AMP Deaminase; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cel

1984